Edwards Lifesciences (EW) Treasury Shares (2009 - 2026)

Edwards Lifesciences' Treasury Shares history runs 18 years deep, the most recent figure standing at $7.5 billion for Q1 2026.

• On a quarterly basis, Treasury Shares rose 16.48% year-over-year to $7.5 billion in Q1 2026; TTM through Mar 2026 was $7.5 billion, a 16.48% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 14.52% from the prior year.
• Treasury Shares climbed to $7.5 billion in Q1 2026 per EW's latest filing, from $7.1 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $83.0 million in Q1 2026 and bottomed at $21.5 million in Q1 2022.
• The 5-year median for Treasury Shares is $49.4 million (2023), against an average of $52.7 million.
• Across the five-year window, Treasury Shares soared 71.46% in 2022 and advanced 14.37% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $4.1 billion in 2022, then grew by 21.25% to $5.0 billion in 2023, then gained by 23.24% to $6.2 billion in 2024, then rose by 14.52% to $7.1 billion in 2025, then increased by 5.95% to $7.5 billion in 2026.
• Per Business Quant, the three latest EW Treasury Shares figures stand at $7.5 billion (Q1 2026), $7.1 billion (Q4 2025), and $7.0 billion (Q3 2025).